18. MSH Regulatory 1
MSH Regulatory
1. Yoon SW, Chun JS, Sung MH, Kim JY, Poo H. alpha-MSH inhibits TNF-alphainduced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor kappaB signaling in human chondrosarcoma HTB-94 cells. Osteoarthritis Cartilage 2007; [Epub ahead of print].
2. Crown A, Clifton DK, Steiner RA. Neuropeptide signaling in the integration of metabolism and reproduction. Neuroendocrinology 2007; [Epub ahead of print].
3. Forlano PM, Cone RD. Conserved neurochemical pathways involved in hypothalamic control of energy homeostasis. J Comp Neurol 2007; 505(3): 235248.
4. Hoggard N, Rayner DV, Johnston SL, Speakman JR. Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice. J mol Endrocrinol 2004; 33(3): 693-703.
5. Hoggard N, Hunter L, Duncan JS, Rayner DV. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signaling system. J Mol Endocrinol 2004; 32(1): 145-153.
6. Hoggard N, Johnstone AM, Faber P, Gibney ER, Elia M, Lobley G, Rayner V, Horgan G, Hunter L, Bashir S, Stubbs RJ. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf) 2004; 61(1): 31-39.
7. Capsoni F, Ongari A, Colombo G, Turcatti F, Catania A. The synthetic melanocortin (CKPV)(2) exerts broad anti-inflammatory effects in human neutrophils. Peptides 2007; 28(10): 2016-2022.
8. Gatti S, Carlin A, Sordi A, Leonardi P, Colombo G, Fassati LR, Lipton JM, Catania A. Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions. J Surg Res 2006; 131(2): 209-214.
9. Catania A, Cutuli M, Garofalo L, Airaghi L, Valenza F, Lipton JM, Gattinoni L. Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit Care Med 2000; 28(5): 1403-1407.
10. Yamaoka-Tojo M, Tojo T, Shioi T, Masuda T, Inomata T, Izumi T. Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Intern Med 2006; 45(7): 429-434.
11. Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, Galimberti D, Baron P, Lipton JM, Catania A. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol 1998; 63(6):740-745.
12. Ledeboer A, Breve JJ, Poole S, Tilders FJ, Van Dam AM. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia 2000; 30(2): 134142.
13. Matias I, Vergoni AV, Petrosino S, Ottani A, Pocai A, Bertonlini A, Di Marzo V. Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: insulin and melanocortins. Neuropharmacology 2007; [Epub ahead of print].
14. Guijarro A, Laviano A, Meguid MM. Hypothalamic integration of immune function and metabolism. Prog Brain Res 2006; 153: 367-405.
15. Tachibana T, Oikawa D, Adachi N, Boswell T, Furuse M. Central administration of alpha-melanocyte-stimulating hormone changes lipid metabolism in chicks. Comp Biochem Physiol A Mol Integr Physiol 2007; 148(2): 408-412.
16. Tachibana T, Oikawa D, Adachi N, Boswell T, Furuse M. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks. Comp Biochem Physiol A Mol Integr Physiol 2007; 147(1): 156-164.
17. Caruso C, Durand D, Schioth HB, Rey R, Seilicovich A, Lasaga M. Activation of melanocortion 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology 2007; 148(10): 4918-4926.
18. Caruso C, Mohn C, Karara AL, Rettori V, Watanobe H, Schioth HB, Seilicovich A, Lasaga M. Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 2004; 79(5): 278-286.
19. Cragnolini AB, Perello M, Schioth HB, Scimonelli TN. Alpha-MSH and gammaMSH inhibit IL-1beta induced activation of the hypothalamic-pituitary axis through central melanocortin receptors. Ragul Pept 2004; 122(3): 185-190.
20. Glavas MM, Joachim SE, Draper SJ, Smith MS, Grove KL. Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat. Endocrinology 2007; 148(7): 3279-3287.
21. Foster DC, Piekarz KH, Murant TI, LaPoint R, Haidaris CG. Phipps RP. Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis. Am J Obestet Gynecol 2007; 196(4): 346.
22. Colombo G, Gatti S, Sordi A, Turcatti F, Carlin A, Rossi C, Lonati C, Catania A. Production and effects of alpha-melanocyte-stimulating hormone during acute lung injury. Shock 2007; 27(3): 326-333.
23. Taylor AW. Ocular immunosuppressive microenvironment. Chem Immunol Allergy 2007; 92: 71-85.
24. Perello M, Stuart RC, Nillni EA. Differential effects of fasting and leptin on proopiomelanocortin peptides in the arcuate nucleus and in the nucleus of the solitary tract. Am J Physiol Endocrinol Metab 2007; 292(5): E1348-1357.
25. Maaser C, Kannengiesser K, Kucharzik T. Role of the melanocortin system in inflammation. Ann N Y Acad Sci 2006; 1072: 123-134.
26. Cragnolini AB, Caruso C, Lasaga M, Scimonelli TN. Alpha-MSH and gammaMSH modulate early release of hypothalamic PGE2 and NO induced by IL-1beta differently. Neurosci Lett 2006; 409(3): 168-172.
27. Dhillo WS, Small CJ, Seal LJ, Kim MS, Stanley SA, Murphy KG, Ghatei MA, Bloom SR. The hypothalamic melanocortin system stimulates the hypothalamopituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinology 2002; 75(4): 209-216.
28. Bjorbaek C, Hollenberg AN. Leptin and melanocortin signaling in the hypothalamus. Vitam Horm 2002; 65: 281-311.
29. Dube MG, Pu S, Kalra SP, Kalra PS. Melanocortin signaling is decreased during neurotoxin-induced transient hyperphagia and increased body-weight gain. Peptides 2000; 21(6): 793-801.
30. Shimizu H, Inoue K, Mori M. The leptin-dependent and independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol 2007; 193(1): 1-9.
31. Mounien L, Bizet P, Boutelet I, Gourcerol G, Fournier A, Vaudry H, Jegou S. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Neuroscience 2006; 143(1): 155-163.
32. Masman MF, Rodriguez AM, Svetaz L, Zacchino SA, Somlai C, Csizmadia IG, Penke B, Enriz RD. Synthesis and conformational analysis of His-Phe-Arg TrpNH2 and analogues with antifungal properties. Bioorg Med Chem 2006; 14(22): 7604-7614.
33. Colombo G, Sordi A, Turcatti F, Carlin A, Rossi C, Lonati C, Santambrogio L, Gatti S, Catania A. Change in gene expression profile induced by alphamelanocyte stimulating hormone in a malignant mesothelioma cell line. Cell Mol Biol (Noisy-le-grand) 2006; 52(2): 69-74.
34. Colombo G, Gatti S, Turcatti F, Sordi A, Fassati LR, Bonino F, Lipton JM, Catania A. Gene expression profiling reveals multiple protective influences of the peptide alpha-melanocyte-stimulating hormone in experimental heart transplantation. J Immunol 2005; 175(5): 3391-3401.
35. Lindberg C, Hijorth E, Post C, Winblad B, Schultzberg M. Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-stimulating hormone. Neurotox Res 2005; 8(3-4): 267-276.
36. Delgado Hernandez R, Demitri MT, Carlin A, Meazza C, Villa P, Ghezzi P, Lipton JM, Catania A. Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte-stimulating hormone. Neuroimmunodulation 1999; 6(3): 187-192.
37. Chiao H, Foster S, Thomas R, Lipton J, Star RA. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1996; 97(9): 2038-2044.
38. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. Alpha-melanocytestimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997; 99(6): 1165-1172.
39. Nishida T, Miyata S, Itoh Y, Mizuki N, Ohgami K, Shiratori K, Ilieva IB, Ohno S, Taylor AW. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol 2004; 4(8): 10591066.
40. Bohm M, Schiller M, Luger TA. Non-pigmentary actions of alpha-melanocytestimulating hormone-lessons from the cutaneous melanocortin system. Cell Mol Biol (Noisy-le-grand) 2006; 52(2): 61-68.
41. Bohm M, Eickelmann M, Li Z, Schneider SW, Oji V, Diederichs S, Barsh GS, Vogt A, Stieler K, Blume-Peytavi U, Luger TA. Detection of functionally active melanocortin receptors and evidence for an immunoregulatory activity of alphamelanocyte-stimulating hormone in human dermal papilla cells. Endocrinology 2005; 146(11): 4635-4646.
42. Biros DJ, Namba K, Taylor AW. Alpha-MSH regulates protein ubiquitination in T cells. Cell Mol Biol (Noisy-le-grand) 2006; 52(2): 33-38.
43. Taylor A, Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol 2001; 79(4): 358-367.
44. Taylor AW, Yee DG, Nishida T, Namba K. Neuropeptide regulation of immunity. The immunosuppressive activity of alpha-melanocyte-stimulating hormone (alpha-MSH). Ann N Y Acad Sci 2000; 917: 239-247.
45. Namba K, Kitaichi N, Nishida T, Taylor AW. Induction of regulatory T cells by the immunodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta 2. J Leukoc Biol 2002; 72(5): 946-952.
46. Rouzaud F, Hearing VJ. Analysis of the transcriptional regulation of melanocytic genes by alpha MSH using the cDNA microarray technique. Cell Mol Biol (Noisy-le-grand) 2006; 52(2): 21-31.
47. Beiret L, Flori E, Denoyelle C, Bille K, Busca R, Picardo M, Bertolotto C, Ballotti R. Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J Biol Chem 2007; 282(19): 14140-14147.
48. Sabatier N. alpha-Melanocyte-stimulating hormone and oxytocin: a peptide signaling cascade in the hypothalamus. J Neuroendocrinol 2006; 18(9): 703-710.
49. Caquineau C, Leng G, Guan XM, Jiang M, Van der Ploeg L, Douglas AJ. Effects of alpha-melanocyte-stimulating hormone on magnocellular oxytocin neurons and their activation at intromission in male rats. J Neuroendocrinol 2006; 18(9): 685691.
50. Sabatier N, Caquineau C, Douglas AJ, Leng G. Oxytocin released from magnocellular dendrities: a potential modulator of alpha-melanocyte-stimulating hormone behavioral actions? Ann N Y Acad Sci 2003; 994: 218-224.
51. Wotjak CT, Naruo T, Muraoka S, Simchen R, Landgraf R, Engelmann M. Forced swimming stimulates the expression of vasopressin and oxytocin in magnocellular neurons of the rat hypothalamic paraventricular nucleus. Eur J Neurosci 2001; 13(12): 2273-2281.
52. Sabatier N, Caquineau C, Dayanithi G, Bull P, Douglas AJ, Guan XM, Jiang M, Van der Ploeg L, Leng G. Alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dentrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis. J Neurosci 2003; 23(32): 10351-10358.
53. Guijarro A, Laviano A, Meguid MM. Hypothalamic integration of immune function and metabolism. Prog Brain Res 2006; 153: 367-405.
54. Wang CH, Lee TH, Lu CN, Chou WY, Hung KS, Concejero AM, Jawan B. Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation. Gene Ther 2006; 13(13): 1000-1009.
55. Chou WY, Lu CN, Lee TH, Wu CL, Hung KS, Concejero AM, Jawan B, Wang CH. Electroporative interleukin-10 gene transfer ameliorates carbon tetrachlorideinduced murine liver fibrosis by MMP and TIMP modulation. Acta Pharmacol Sin 2006; 27(4): 469-476.
56. Shi MN, Huang YH, Zheng WD, Zhang LJ, Chen ZX, Wang XZ. Relationship between transforming growth factor beta 1 and anti-fibrotic effect of interleukin10. World J Gastroenterol 2006; 12(15): 2357-2362.
57. Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV. Rat pancreatic stellate cells secrete matrix turnover. Gut 2003; 52(2): 275282.
58. Braundmeier AG, Nowak RA. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Am J Reprod Immunol 2006; 56(3): 201-214.
59. Sasaki M, Kashima M, Ito T, Watanabe A, Izumiyama N, Sano M, Kagaya M, Shioya T, Miura M. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin1beta and TNF-alpha. Mediators Inflamm 2000; 9(3-4): 155-160.
60. Getting SJ. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 2006; 111(1): 1-15.
61. Tatro JB. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation 1996; 3(5): 259284.
62. Manna SK, Sarkar A, Sreenivasan Y. Alpha-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. Eur J Immunol 2006; 36(3): 754-769.
63. Luger TA, Scholzen TE, Brzoska T, Bohm M. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann N Y Sci 2003; 994: 133-140.
64. Luger TA, Kalden D, Scholzen TE, Brzoska T. alpha-melanocyte-stimulating hormone as a mediator of tolerance induction. Pathobiology 1999; 67(5-6): 318321.
65. Grabbe S, Bhardwaj RS, Mahnke K, Simon MM, Schwarz T, Luger TA. AlphaMelanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 1996; 156(2): 473-478.
66. Catania A, Gatti S, Colombo G, Lipton JM. Alpha-melanocyte stimulating hormone in modulation of inflammatory reactions. Pediatr Endocrinol Rev 2003;1(2): 101-108.
67. Oktar BK, Alican I. Modulation of the peripheral and central inflammatory responses by alpha-melanocyte stimulating hormone. Curr Protein Pept Sci 2002; 3(6): 623-628.
68. Ichiyama T, Sato S, Okada K, Catania A, Lipton JM. The neuroimmunomodulatory peptide alpha-MSH. Ann N Y Acad Sci 2000; 917: 221-226.
69. Lipton JM, Catania A. Mechanisms of anti-inflammatory action of the neuroimmunomodulatory peptide alpha-MSH. Ann N Y Acad Sci 1998; 840: 373-380.
70. Forslin Aronsson S, Spulber S, Popescu LM, Winblad B, Post C, Oprica M, Schultzberg M. alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides 2006; 40(1): 65-75.
71. Vulliemoz NR, Xiao E, Xia-Zhang L, Ferin M, Wardlaw SL. Melanocortin modulation of inflammatory cytokine and neuroendocrine responses to endotoxin in the monkey. Endocrinology 2006; 147(4): 1878-1883.
72. Kawauchi H, Sower SA. The dawn and evolution of hormones in the adenohypophysis. Gen Comp Endocrinol 2006; 148(1): 3-14.
73. Ellacott KL, Halatchev IG, Cone RD. Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis. Peptides 2006; 27(2): 340-349.
74. Zhang Y, Scarpace PJ. Circumventing central leptin resistance: lessons from central leptin and POMC gene delivery. Peptides 2006; 27(2): 350-364.
75. Cooper A, Robinson SJ, Pickard C, Jackson CL, Friedmann PS, Healy E. Alphamelanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 2005; 175(7): 4806-4813.
76. Cui HS, Hayasaka S, Zhang XY, Chi ZL, Hayasaka Y. Effect of alphamelanocyte-stimulating hormone on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line. Ophthalmic Res 2005; 37(5): 279-288.
77. Cui HS, Hayasaka S, Zhang XY, Hayasaka Y, Chi ZL, Zheng LS. Effect of berberrubine on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line. Life Sci 2006; 79(10): 949-956.
78. Zhang XY, Hayasaka S, Chi ZL, Cui HS, Hayasaka Y. Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on IL-6, IL-8, and MCP-1 expression in human retinal pigment epithelial cell line. Curr Eye Res 2005; 30(12): 1105-1111.
79. Cui HS, Hayasaka S, Zhang XY, Chi ZL, Hayasaka Y. Effect of alphamelanocyte-stimulating hormone on interleukin 8 and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line. Ophthalmic Res 2005; 37(5): 279-288.
80. Cui HS, Hayasaka S, Zhang XY, Hayasaka Y, Chi ZL, Zheng LS. Effect of berberine on interleukin 8and monocyte chemotactic protein 1 expression in a human retinal pigment epithelial cell line. Ophthalmic Res 2006; 38(3): 149-157.
81. Tonosaki Y, Nishiyama K, Roubos EW, Sugiura Y. alpha-Melanophorestimulating hormone (alpha-MSH) antagonizes interleukin-1beta-induced hyperalgesia and Fos expression in the paraventricular and arcuate nucleus of the rat. Neuroendocrinology 2005; 81(3): 167-173.
82. Brogden KA, Guthmiller JM, Salzet M, Zasloff M. The nervous system and innate immunity: the neuropeptide connection. Nat Immunol 2005; 6(6): 558-564.
83. Bowdish DM, Hancock RE. Antiendotoxin properties of cationic host defence peptides and proteins. J Endotoxin Res 2005; 11(4): 230-236.
84. Mookherjee N, Hancock RE. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 2007; 64(7-8): 922-933.
85. Zaiou M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med 2007; 85(4): 317-329.
86. Scott MG, Hancock RE. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 2000; 20(5): 407-431.
87. Mastronardi CA, Srivastava V, Yu WH, Les Dees W, McCann SM. Lipopolysaccharide-induced leptin synthesis and release are differentially controlled by alpha-melanocyte-stimulating hormone. Neuroimmunomodulation 2005; 12(3): 182-188.
88. Taylor AW. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J Neuroimmunol 2005; 162(1-2): 43-50.
89. Huang YC, Li Z, Harder SD, Soukup JM. Apoptotic and inflammatory effects induced by different particles in human alveolar macrophages. Inhal Toxicol 2004; 16(14): 863-878.
90. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY. Berberine suppresses inflammatory agents-induced interleukin 1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 2007; 56(3): 193-201.
91. Tims MC, Batista C. Effects of Root Isoquinoline alkaloids from Hydrastis Canadensis on Furarium oxysporum isolated from Hydrastis root tissue. J Chem Ecol 2007; [Epub ahead of print].
92. Taylor AW. Ocular immunosuppressive microenvironment. Chem Immunol Allergy 2007; 92: 71-85.
93. Scarlett JM, Jobst EE, Enrioro PJ, Bowe DD, Batra AK, Grant WF, Cowley MA, Marks DL. Regulation of central melanocortin signaling by interleukin-1beta. Endocrinology 2007; 148(9): 4217-4225.
94. Guijarro A, Laviano A, Meguid MM. Hypothalamic integration of immune function and metabolism. Prog Brain Res 2006; 153: 367-405.
95. Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 2005; 1056: 218-233.
96. Mastronardi CA, Srivastava V, Yu WH, Les Dees W, McCann SM. Lipopolysaccharide-induced leptin synthesis and release are differentially controlled by alpha-melanocyte-stimulating hormone. Neuroimmunomodulation 2005; 12(3): 182-188.
97. Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, FrokiAEr J, Nielsen S. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQP's and sodium transporters in rat kidney. Kidney Int 2004; 66(2): 683-695.
98. Bohm M, Raghunath M, Sunderkotter C, Schiller M, Stander S, Brzoska T, Cauvet T, Schioth HB, Schwarz T, Luger TA. Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone. J Biol Chem 2004; 279(8): 6959-6966.
03. MARCoNS 2
1. Roberts ME, Stewart PS. Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation. Antimicro Agents Chemo 2004; 48(1): 48-52.
2. Tenover FC, Killgore G, O'Hara CM, Jevitt L, Patel LK, Bozdogan B. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicro Agents Chemo 2004; 48(1): 275-80.
3. Perego M, Hoch JA, Barrett JF. Meeting review: Functional genomics of grampositive microorganisms. J Bacterial 2004; 186(4): 903-9.
4. Robinson DA, Enright MC. Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacterial 2004; 186(4): 1060-64.
5. Webster NS, Smith LD, Heyward AJ, Watts JEM, Webb RI, Blackall LL, Negri AP. Metamorphosis of a scleractinian coral in response to microbial biofilms. Appl Env Micro 2004; 70(2): 1213-21.
6. Olofsson AC, Hermansson M, Elwing H. N-acetyl-cycteine affects growth, extracellular polysaccharide production and bacterial biofilm formation of solid surfaces. Appl Env Micro 2003; 69(8): 4814-22.
7. Robinson DA, Enright MC. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicro Agents Chemo 2003; 47(12): 3926-3934.
8. Walters MC III, Roe F, Bugincourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitations and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicro Agents Chemo 2003; 47(1): 317-23.
9. Sulakvelidze A, Alavidze A, Morris JG. Minireview: Bacteriophage therapy. Antimicro Agents Chemo 2001; 45(3): 649-59.
10. Quershi FM, Badar U, Ahmed N. Biosorption of copper by a bacterial biofilm on a flexible polyvinyl chloride conduit. Appl Env Micro 2001. 67(9): 4349-52.
11. Selifonova O, Valle F, Schellenberger V. Rapid evolution of novel traits in microorganisms. Appl Env Micro 2001; 67(8): 3645-49.
12. Teizel GM, Parsek MR. Heavy metal resistance of biofilm and planktonic Pseudomonas aeruginosa. Appl Env Micro 2003: 69(4): 2313-20.
13. Waar K, van der Mei HC, Harmsen HJM, Degener JE, Busscher HJ. Adhesion to bile materials and physiochemical surface properties of Enterococcus faecalis strains grown in the presence of bile. Appl Env Micro 2002; 68(8): 3855-58.
14. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Env Micro 2002; 68(11): 5459-63.
15. Volger AJ, Busch JD, Percy-Fine S, Tipton-Hunton C, Smith K, Keim P. Notes; molecular analysis of rifampin resistance in Bacillus anthracis and Bacillus cereus. Antimicro Agents Chemo 2002; 46(2): 511-13.
16. Ramage G, Walle KV, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicro Agents Chemo 2001; 45(9): 2475-79.
17. Vaudaux P, Francois P, Bisognano C, Schrenzel J, Lew DP. Comparison of levofloxacin, alatrofloxacin and vancomycin for prophylaxis and treatment of experimental foreign-body associated infection by methicillin-resistant Staphylococcus aureus. Antimicro Agents Chemo 2002; 46(5): 1503-9.
18. Wichelhaus TA, Boddinghaus B, Besier S, Schafer V, Brade V, Ludwig A. Biological cost of rifampin resistance from the perspective of Staphylococcus aureus. Antimicro Agents Chemo 2002; 46(11): 3381-85.
19. Schwarz S, Kehrenberg C, Ojo KK. Staphylococcus scuri gene erm (33), encoding inducible resistance to macrolides, lincosamides, and strepogramin b antibodies, is a product of recombination between erm (C) and erm (A). Antimicro Agents Chemo 2002; 46(11): 3621-23.
20. Ramage G, ValdeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents performed Candida albicans biofilms determined by time-kill studies. Antimicro Agents Chemo 2002; 46(11): 3634-36.
21. Rasooly A, Weisz A. In vitro antibacterial activities of phloxine B and other halogenated flouresceins against methicillin-resistant Staphylococcus aureus. Antimicro Agents Chemo 2002; 46(11): 3650-53.
22. Stone G, Wood P, Dixon L, Leyhan M, atin A. Tetracycline rapidly reaches all the constituent cells of uropathogenic Escherichia coli biofilms. Antimicro Agents Chemo 2002; 46(8): 2458-61.
23. Zahller J, Stewart PS. Transmission electron microscope study of antibiotic action of Klebsiella pneumoniae biofilm. Antimicro Agents Chemo 2002; 46(8): 2679-83.
24. Stoodley P, Wilson S, Hall-Stoodley L, Boyle JD, Lappin-Scott HM, Costerton JW. Growth and detachment of cell clusters from mature mixed-species biofilms. Appl Env Micro 2001; 67(12): 5608-13.
25. Wen ZT, Burne RA. Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans. Appl Env Micro 2002; 68(3): 1196-1203.
26. Oosthuizen MC, Steyn B, Theron J, Cosette P, Lindsay D, Von Holy A, Brozel VS. Proteomic analysis reveals differential protein expression by Bacillus cereus during biofilm formation. Apply Env Micro 2002; 68(6): 2770-80.
27. Williams RJ, Henderson B, Sharp LJ, Nair SP. Identification of a birbonectinbinding protein from Staphylococcus epidermidis. Inf Immun 2002; 70(12): 6805-10.
28. Rickard AH, Leach SA, Hall LS, Buswell CM, High NJ, Handley PS. Phylogenetic relationships and coaggregation ability of freshwater biofilm bacteria. Appl Env Micro 2002 68(7): 3644-50.
29. Puredorj B, Costerton JW, Stoodley P. Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Appl Env Micro 2002; 68(9); 4457-64.
30. Tcholakian RK, Raad II. Durability of anti-infective effect of long-term silicone sheath catheters impregnated with antimicrobial agents. Antimicro Agents Chemo 2001: 45(7): 1990-93.
31. Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicro Agents Chemo 2002; 46(3): 900-3.
32. Schmisser C, Stockigt C, Raasch C., Wingender J, Timmis KN, Wenderoth DF, Flemming HC, Liesgang H, Schmitz RA, Jaeger KE, Streit WR. Metagenome survey of biofilms on drinking water networks. Appl Env Micro 2003; 69(12): 7298-309.
33. Prouty AM, Schweisinger WH, Gunn JS. Biofilm formation and interaction with the surfaces of gallstones by Salmonella spp. Inf Immun 2002; 70(5): 2640-49.
34. Polonio RE, Mermel LA, Paquette GE, Sperry JF. Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salcylate and vancomycin. Antimicro Agents Chemo 2001; 45(11): 3262-66.
35. Vance RE, Zhu J, Mekalanos JJ. A constitutively active variant of the quorumsensing regulator LuxO affects protease production and biofilm formation. Inf Immun 2003; 71(5): 5271-76.
36. Yan L, Boyd KG, Adams DR, Burgess JG. Biofilm-specific-cross-species induction of antimicrobial compounds in bacilli. Appl Env Micro 2003; 69(7): 3719-27.
37. Lee JH. Methicillin (oxacillin)-resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans. Apply Env Micro 2003; 69(11): 6489-94.
38. Joseph LA, Wright AC. Expression in Vibrio vulnificus capsular polysaccharide inhibits biofilm formation. J Bacter 2004; 186(3): 889-93.
39. Lim Y, Jana M, Luong TT, Lee CY. Control of glucose- and NaCL induced biofilm formation by rbf in Staphylococcus aureus. J Bacter 2004; 86(3): 722-29.
40. Kristich CJ, Li YH, Cvitkovitch DG, Dunny GM. Esp-independent biofilm formation by Enterococcus faecalis. J Bacter 2004'; 186(1): 154-63.
41. Wisplinghoff H, Rosato AE, Enright MC, Noto M, Craig W, Archer GL. Related clones containing SCCmed type IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicro Agents Chemo 2003; 47(11): 3574-79.
42. Wu JA, Kusuma C, Momd JJ, Kokai-Kun JF. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicro Agents Chemo 2003; 47(11); 3407-14.
43. Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicro Agents Chemo 2003; 47(11): 3580-85.
44. Bachmann SP, Ramage G, VandeWalle K, Patterson TF, Wickes BL, LopezRibot JL. Antifungal combinations against Candida albicans biofilm in vitro. Anitmicro Agents Chemo 2003; 47(11): 3657-59.
45. Von Eiff C, Kokai-Kun JF, Becker K, Peters G. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood. Antimicro Agents Chemo 2003; 47(11): 3613-15.
46. Kozitskaya S, Cho SH, Dietrich K, Marre R, Naber K, Ziebuhr W. the bacterial insertion sequence element IS2356 isolates: association with biofilm and resistance to aminoglycosides. Inf Immun 2004; 72(2): 1210-15.
47. Leid JG, Shirtliff ME, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate and respond to Staphylococcus aureus biofilms. Inf Immun 2002; 70(11): 6339-6345.
48. Head, NE, Yu H. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilms formation, virulence, and genome diversity. Inf Immun 2004; 72(1): 133-44.
49. Domenico P, Baldassarri L, Schoch PE, Kaehler K, Sasatsu M, Cunha BA. Activities of bismuth thiols against Staphylococci and Staphylococcal biofilms. Antimicro Agents Chemo 2001; 45(5): 1417-21.
50. Linde HJ, Schmidt M, Fuchs E, Reischl U, Niller HH, Lehn N. In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and Coagulase-negative Staphylococci. Antimicro Agents Chemo 2001; 45(5): 155357.
51. Curtin J, Cormican M., Fleming G, keelehan J, Colleran E. Linezolid compared with eperezolid, vancomycin, and gentamicin in and in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicro Agents Chemo 2003; 47(10): 314548.
52. Giacometti A, Cirione O, Ghisello R, Orlando F, Mocchegiani F, Riva A, Del Prete S, Saba V, Scalise G. Efficacy of quinupristin-dalopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. Antimicro Agents Chemo 2002; 46(9): 2885-88.
53. Pruner AL, Malbruny B, Tande D, Picard B, Leclargq R. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicro Agents Chemo 2002; 46(9): 3054-56.
54. Kokai-Kun JF, Walsh SM, Chanturiya T, Mond JJ. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicro Agents Chemo 2003; 47(5): 1589-97.
55. Hendley JO, Ashe KM. Eradication of resident bacteria of normal human skin by antimicrobial ointment. Antimicro Agents Chemo 2003; 47(6): 1988-90.
56. Giacometti F, Scalise G, Balaban N, Acqua GD. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. Antimicro Agents Chemo 2003; 47(6): 1979-83.
57. Singh R, Stine OC, Smith DL, Spitznagel JK Jr., Labib ME, Williams HN. Microbial diversity of biofilms in dental unit water systems. Appl Env Micro 2003; 69(6); 3412-3420.
58. Alem MAS, Douglas LJ. Effects of aspirin and other nonsteroidal anitinflammatory drugs on biofilms and plkanktonic cells and Candida albicans. Antimicro Agents Chemo 2004; 48(1): 41-7.
59. Di Bonaventura G, Spedicato H, D'Antonio D, Robuffo I, Piccolomini R. Biofilm formation by Stenotrophomas maltophilia: modulation by quinolones, trimethoprim sulfamethoxazole, and ceftazidime. Antimicro Agents Chemo 2004; 48(1): 151-60.
60. Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicro Agents Chemo 2003; 47(4): 1251-56.
61. Else TA, Pantle CR, Amy PS. Boundaries for biofilm formation: humidity and temperature. Appl Env Micro 2003; 69(8): 5006-10.
62. Gilmore KS, Srinivas P, Adkins DR, Hatter KL, Gilmore MS. Growth, development and gene expression in a persistent Streptococcus gordonii biofilm. Inf Immun 71(8): 4759-66.
63. Kievit TR, Gillis R, Marx S, Brown C, Iglewski BH. Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns. Appl Env Micro 2001; 67(4): 1865-73.
64. Frederick JR, Elkins JG, Bollinger N, Hassett DJ, McDermott TR. Factors affecting catalase expression in Pseudomonas aeruginosa biofilms and planktonic cells. Appl Env Micro 2001; 67(3): 1375-79.
65. Guggenheim M, Shapiro S, Gmur R, Guggenheim B. Spatial arrangements and associative behavior of species in an in vitro oral biofilm model. Appl Env Micro 2001; 67(3): 1343-50.
66. Geiseke A, Purkold U, Wagner M, Amann R, Schramm A. Community structure and activity dynamics of nitrifying bacteria in a phosphate-removing biofilm. Appl Env Micro 2001; 67(3): 1351-62.
67. Bassiere C, Burckner R, Talon R. Characterization of the single superoxide dismutase of Staphylococcus xylosus. Appl Env Micro 2001; 67(6): 4096-4104.
68. Francoeur SN, Wetzel RG, Neely RK. New spatially explicit method for detecting extracellular protease activity in biofilm. Appl Env Micro 2001; 67(9): 4329-34.
69. Battin TJ, Kaplan LA, Newbold JD, Cheng X, Hansen C. Effects of current velocity on the nacent architecture of stream microbial biofilms. Appl Env Micro 2003; 69(9): 5443-52.
70. Antonio, McFerran N, Pallen MJ. Mutations affecting of Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus. Antimicro Agents Chemo 2002; 46(2): 438-42.
71. Darouiche RO, Fowler VG, Adal K, Kielhofner M, Mansouri D, Reller LB. Antimicrobial activity of prosthetic heart value sewing cuffs coated with minocycline and rifampin. Antimicro Agents Chemo 2002; 46(2): 543-5.
72. Campanac C, Pineau L, Payard A, Baziard-Mouysset G, Roques C. Interactions between biocide cationic agents and bacterial biofilms. Antimicro Agents Chemo 2002; 46(5); 1469-74.
73. Aubrey-Damon H, Galimand M, Gerbaud G, Couvalin P. rpoB mutation conferred rifampin resistance in Streptococcus pyogenes. Antimicro Agents Chemo 2002; 46(5): 1571-73.
74. Fan F, Yan K, Wallis NG, Reed S, Moore TD, Rittenhouse SF, DeWolf WE, Huang J, McDevitt D, Miller WH, Seefeld MA, Newlander KA, Jakas DR, Head MS, Paye DJ. Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicro Agents Chemo 2002; 46(11): 3343-47.
75. Anthonsisen IL, Sunde M, Steinum TM, Sidhu MS, Sorum H. Organization of the antiseptic resistance gene qaca and Tn552-related B-lactamase gene in multidrug-resistant Staphylococcus haemolyticus strains of animal and human origins. Antimicro Agents Chemo 2002; 46(11): 3606-12.
76. Bcker K, Keller B, Von Eiff C, Mruck M, Lubritz G, Etienne J, Peters G. Enterotoxigenic potential of Staphylococcus intermedius. Appl Env Micro 2001; 67(12): 5551-7.
77. Djordjevic D, Wiedmann M, McLandsborough LA. Microtiter plate assay for assessment of Listeria monocytogenes biofilm formation. Appl Env Micro. 2002; 68(6): 2950-58.
78. Becker P Hufnagle W, Peters G, Hermann M. Detection of differential gene expression ion biofilm-forming versus planktonic populations of Staphylococcus aureus using micro-representational-difference analysis. Appl Env Micro 2001; 67(7): 2958-65.
79. Coquet L, Cossett P, Qullet L, Petit F, Junter GA, Jouenne T. Occurrence and phenotypic characteristics of Versinia ruckeri strains with biofilm-forming capacity in a rainbow trout farm. Appl Env Micro 2002; 68(2): 470-75.
80. Cucarella C, Tormo MA, Knecht E, Amorena B, Lasa I, Foster TJ, Penades JR. Expression of the biofilm-associated protein interferes with host protein receptors of Staphylococcus aureus and alters the infective process. Inf Immun 2002; 70(6): 3180-86.
81. Borucki MK, Peppin JD, White D, Loge F, Call DR. Variation in biofilm formation among strains of Listeria monocytogenes. Appl Env Micro 2003; 69(12); 7336-42.
82. Bolken TC, Franke CA, Jones KF, Bell RH, Swanson RM, Kings DS, Fischette VA, Hruby DE. Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram positive commensal vectors. Inf Immun 2002; 70(5): 2487-91.
83. Chen W, Palmer RJ, Kuramitsu HK. Role of polyphosphate kinase in biofilm formation by Porphyromonas gingivalis. Inf immun 2002; 70(8): 4708-15.
84. Colin DA, Monteil H. Control of the oxidative burst of human neutrophilis by Staphylococcus leukotoxins. Inf Immun 2003; 71(7): 3724-29.
85. Fitzgerald JR, Reid SD, Ruotsalainen E, Tripp TJ, Liu MY, Cole R, Kuusela P, Schlievert PM, Jarvinen A, Musser JM. Genome diversification in Staphylococcus aureus: molecular evolution of a highly variable chromosomal region encoding the staphylococcal exotoxin-like family of proteins. Inf Immun 2003; 71(5): 2827-38.
86. Hanssen AM, Kjeldsen G, Sollid JUE. Local variants of staphylococcal cassette chromosome mec in sporadic methicillin-resistance Staphylococcus aureus and methicillin-resistant coagulose-negative staphylococci: evidence of horizontal gene transfer. Antimicro Agents Chemo 2004; 48(1): 285-96.
87. Marsollier L, Stinear T, Aurby J, Andre JPS, Robert R, Legras P, Manceau AL, Audrain C, Bourdon S, Kouajou H, Carbonelle B. Aquatic plants stimulate the growth of and biofilm formation by Mycobacterium ulcerans in axenic culture and harbor these bacteria in the environment. Appl Env Micro 2004;70(2): 10971103.
88. Labthavikul P, Petersen PJ, Bradford PA. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicro Agents Chem 2003; 47(12): 3967-69.
89. Lagouminitzis G, Chrstofidou M, Minitracopoulos G, Paliogianni. Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis alpha gene expression and activation of transcription activators nuclear factors kB and activator protein 1 in human monocytes. Inf Immun 2003; 71(8): 4614-22.
90. Lewis K. Minireview: riddle of biofilm resistance. Antimicro Agents Chemo 2001; 45(4): 999-1007.
91. Kondo N, Kuwahara-Arai K, Kuroda-Murakmi H, Suzuki ET, Kiramatsu K. Eagle-type resistance: new phenotype of high methicillin resistance under mec regulator gene control. Antimicro Agents Chemo 2001; 45(3): 815-24.
92. Lina G, Boutite F, Tristan A, Etienne J, Vandenesch F. Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl Env Micro 2003; 69(1): 18-23.
93. McBain AJ, Bartolo RG, Catenich CE, Charbonneau D, Ledder RG, Rickart AH, Symmons SA, Gilbert P. Microbial characterization of biofilms in domestic drains and the establishment of stable biofilm microcosms. Appl Env Micro 2003; 69(1): 177-85.
94. Kierek K, Watnick PI. Environmental determinants of Vibrio cholerae biofilm development. Appl Env Micro 2003; 69(9): 5079-88.
95. Hendrickx L, Hausner M, Wuertz S. Natural genetic transformation in monoculture acinetobacter sp. Strain BD413 biofilms. Appl Env Micro 2003; 69(3): 1721-27.
96. Moretro T, Hermansen L, Holck AL, Sidhu MS, Rudi K, Langsrud S. Biofilm formation and the presence of the intercellular adhesion locus ICA among staphylococci from food and food processing environments. Appl Env Micro 2003; 69(9): 5648-55.
97. Meier PS, Utz, Aebi S, Muhlemann K. Low-level resistance to rifampin in Streptococcus pneumoniae. Antimicro Agents Chemo 2003; 47(3): 863-68.
98. Knobcloh JKM, Nedelmann M, Kiel K, Bartscht K, Horstkotte MA, Dobinsky S, Rohde H, Mack D. Establishment of an arbitrary PCR for rapid identification of Tn917 insertion sites in Staphylococcus epidermidis: characterization of biofilmnegative and nonmucoid mutans. Appl Env Micro 2003; 69(10: 5812-18.
99. Heydorn A, Ersboll B, Kato J, Hentzer M, Parsek MR, Tolker-Nielsen T, Givskov M, Molin S. Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-tocell signaling, and stationary-phase sigma factor expression. Appl Env Micro 2002; 68(4): 2008-17.
100. Kadrurugamuwa JL, Sin L, Albert E, Yu J, Francis K, DeBoer M, Rubin M, Bellinger-Kawahara C, Parr TR Jr., Contag PR. Direct continuous method for monitoring biofilm infection in a mouse model Inf Immun 2003; 71(2): 882-90.
101. Luppens SBI. Reji MW, Van Der Heijden RWL, Rombouts FM, Abee T. Development of a standard test to assess the resistance of Staphylococcus aureus biofilm cells to disinfectants. Appl Env Micro 2002; 68(9): 4194-200.
102. Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ. Reduction to exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Env Micro 2001; 67(6): 2746-53.
103. Neu TR, Kuhlicke U, Lawrence JR. Assessment of flourochromes for two-photon laser scanning microscopy of biofilms. Appl Env Micro 2002; 68(2): 901-9.
104. Katayama Y, Ito T, Hiramatsu K. Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in macA carrying lowlevel methicillin-resistance Staphylococcus haemolyticus. Antimicro Agents Chemo 2001; 45(7): 1955-63.
105. Mealey KL, Barhoumi R, Burghardt RC, Safe S, Kochevar ST. Doxycycline induces expression of P clycoprotein in MCF-7 breast carcinoma cells. Antimicro Agents Chemo 2001; 46(3): 755-61.
106. Mack D, Sabottke A, Dobinsky S, Rohde H, Horstkotte MA, Knobloch JKM. Differential expression of methicillin resistance by different biofilmnegative Staphylococcus epidermidis transposon mutant classes. Antimicro Agents Chemo 2002; 46(1): 178-83.
107. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Inf Immun 2002; 70(2): 878-88.
108. Kuhn DM, George T, Chandra J, Mukherjee PK, Channoum. Antifungal susceptibility of Candida biofilms: unique effacy of amphotercin B lipid formulations and echinocandins. Antimicro Agents Chemo 2002; 46(6); 1773-80.
109. Kiri N, Archer G, Climo MW. Combinations of lysostaphin with Blactams are synergistic against oxacillin-resistant Staphylococcus epidermidis. Antimicro Agents Chemo 2002; 46(6): 2017-20.
110. Jones ME, Mayfield DC, Thornsberry C, Karlowsky JA, Sahm DF, Peterson D. Letters to the editor: prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000. Antimicro Agents Chemo 2002; 46(9); 3104-3105.
111. Orwin, PM, Fitzgerald JR, Leung DYM, Gutierrez JA, Bohach GA, Schlievert PM. Characterization of Staphylococcus aureus enterotoxin. Inf Immun 2003; 71(5): 2916-19.
112. Keinanen MM, Korhonen JK, Lehtola MJ, Miettinen IT, Martikainen PJ, Vartiainen T, Suutari MH. The microbial community structure of drinking water biofilms can be affected by phosphorus availability. Appl Env Micro 2002; 68(1): 434-9.
113. Fujimura S, Watanbe A, Beighton D. Letters to the editor: characterization of the mupA gene in strains of methicillin-resistant Staphylococcus aureus with a low level of resistance to mupirocin. Antimicro Agents Chemo 2001; 45(2): 641-2.
114. Harbarth S, Cosgrove S, Carmeli Y. Minireview: effects of antibiotics on nosocomial epidemiology of vancomycin-resistant Enterococci. Antimicro Agents Chemo 2002; 46(6): 1619-28.
115. MMI lux/luxR language of bacteria/biofilms/toxins. http://www.biofilmsonline.com/gci-bin/biofilmsonline/00140.
116. McGregor IJ. Coagulase-negative staphylococcal membrane-damaging toxins, pain intensity, and metabolic changes in temporomandibular disorder patients with chronic muscle pain. J Orofac Pain 2003; 17(2): 125-32.
